Research Article

The Use of Antifibrotic Recombinant nAG Protein in a Rat Liver Fibrosis Model

Table 3

The staging of liver fibrosis in the two experimental groups.

Degree of FibrosisGroup II: CCL4 onlyGroup III: CCL4 and nAG
(n=15 rats)(n=15 rats)

No or mild fibrosis2 (both rats had mild fibrosis)9 (3 rats had no fibrosis and 6 rats had mild fibrosis)

Moderate to severe fibrosis13 (4 rats had moderate fibrosis and 9 rats had severe fibrosis)6 (4 rats had moderate fibrosis and 2 rats had severe fibrosis)

P= 0.008.